Clinical Trial

A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study will assess the effcacy and safety of 610 as an adjunctive therapy in adult subjects with severe eosinophilic asthma.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-11-07; most recent amendment 2026-01-27.
Status change: Recruiting → Active, Not Recruiting 2026-01-27
Status change: Not Yet Recruiting → Recruiting 2026-01-04
Trial Details
NCT Number NCT06680947
Lead Sponsor Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions Asthma
Enrollment 225 participants
Start Date 2024-12-20
Primary Completion 2027-02 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-29